NextPlat (NXPL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Annual Meeting scheduled for June 24, 2026, will be held virtually with no physical location; shareholders can participate and vote online or by phone.
Record date for voting is April 27, 2026; 2,708,507 shares are outstanding and entitled to vote.
Proxy materials, including the Proxy Statement and Annual Report, are available online to reduce costs and improve accessibility.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of six directors, (2) ratification of RBSM LLP as independent auditor for 2026, (3) advisory approval of executive compensation, (4) authorization to adjourn the meeting if needed, and (5) any other business properly brought before the meeting.
Each share has one vote; cumulative voting is not permitted.
Plurality required for director election; majority required for other proposals.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of six members, four of whom are independent per Nasdaq rules.
Committees include Audit, Compensation, and Nominating, each with independent members.
Board met four times in 2025; all directors attended 100% of meetings.
Board diversity matrix provided; one female and five male directors.
Code of Ethics and Insider Trading Policy are in place.
Latest events from NextPlat
- Record 40% gross margin and $54.3M revenue highlight a successful turnaround and global expansion.NXPL
Corporate presentation - Q2 2026 saw 21% revenue growth, record margins, and sharply reduced net loss.NXPL
Q2 2026 - Turnaround drives margin gains and nationwide healthcare expansion, supporting profitable growth.NXPL
Corporate presentation - All board nominees and proposals were approved by majority vote; results to be filed in Form 8-K.NXPL
AGM 2026 - Registering 2,097,011 shares for resale, with no proceeds to the company and significant dilution risk.NXPL
Registration filing - Turnaround delivers margin expansion, cost cuts, and nationwide healthcare growth.NXPL
Corporate presentation - Record 35% gross margin and reduced losses highlight progress in turnaround and growth.NXPL
Q1 2026 - Turnaround drives margin growth, nationwide expansion, and global e-commerce momentum.NXPL
Corporate presentation - Registering 2.65M shares for resale, with no proceeds to the company and ongoing net losses.NXPL
Registration filing